Tuesday, June 30, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

CMPX — Compass Therapeutics, Inc. SEC Filings | FilingIndex

CMPXNasdaq

Compass Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · DE · CIK 1738021

Developing antibody-based cancer therapeutics targeting angiogenesis, immune response, and tumor growth

+ Watch View on EDGAR ↗

$366M

Market cap

$2.16

Last close

+3.9%

1D

+2.9%

5D

2.8M

Volume

Price · last 39 sessions+11.3%

May 4L $1.81 · H $2.41Jun 29

122

Total filings

Jun 23, 2026

Last filing

12/31

Fiscal year end

All 8-K · 53 10-Q · 24 10-K · 8 SC 13G · 8 424B5 · 7 DEFA14A · 6 DEF 14A · 6 SC 13D · 4

10-QFORM 10-QMay 5, 2026 10-QFORM 10-QNov 5, 2025 10-QFORM 10-QAug 11, 2025 10-QFORM 10-QMay 8, 2025 10-QFORM 10-QNov 12, 2024 10-Q

Similar companies

Comparable business profile · signals at a glance

CBIOCRESCENT BIOPHARMA, INC.$494.1M-3.0%XNCRXencor Inc$914.2M+3.6%JANXJanux Therapeutics, Inc.$826.9M+2.6%CTMXCytomX Therapeutics, Inc.$655.3M+10.0%CGENCOMPUGEN LTD

FORM 10-Q

Aug 12, 2024

10-QFORM 10-QMay 13, 2024

10-QFORM 10-QNov 9, 2023

10-QFORM 10-QAug 3, 2023

10-QFORM 10-QMay 4, 2023

10-QFORM 10-QNov 9, 2022

10-QFORM 10-QAug 1, 2022

10-Q10-QMay 9, 2022

10-Q10-QNov 12, 2021

10-Q10-QAug 16, 2021

10-Q10-QApr 30, 2021

10-Q10-QNov 9, 2020

10-Q10-QAug 13, 2020

10-QQUARTERLY REPORTFeb 14, 2020

10-QQUARTERLY REPORTNov 13, 2019

10-QQUARTERLY REPORTAug 13, 2019

10-QQUARTERLY REPORTFeb 14, 2019

10-QQUARTERLY REPORTNov 14, 2018

10-QQUARTERLY REPORTAug 14, 2018

$193.0M

+3.4%

CLDXCelldex Therapeutics, Inc.$2.5B+6.2%